Status:
NOT_YET_RECRUITING
Percutaneous Cryoablation of Intercostal Nerves for the Treatment of Rib Fractures
Lead Sponsor:
Loma Linda University
Conditions:
Trauma
Rib Fractures
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The goal of this double blinded randomized control trial is to learn if percutaneous cryoablation of traumatic rib fractures improves outcomes. The main questions it aims to answer are: Does percutan...
Eligibility Criteria
Inclusion
- \> 18 years old
- \> 2 rib fractures
- Verbal Pain score \> 5
- Incentive Spirometry \< 60% of predicted
Exclusion
- Isolated Fractures of Ribs 1-3 and/or 10-12
- Posterior Rib Fracture \< 4 cm from costovertebral joint
- Sternal, Clavicle, Scapula Fracture
- Thoracic Spinal Fracture of any type
- Open Abdominothoracic Surgery
- Unstable Spine
- Extensive Subcutaneous Emphysema
- BMI \> 35
- Plan for Rib Plating
- Chronic Opioid Use
- Prior to study enrollment: Intubated, Traumatic Brain Injury, Dementia, Cognitive Impairment, Encephalopathy
- Coagulopathy, Shock at time of ablation
- Inability to participate in activities of daily living prior to injury
- Home O2 use prior to trauma
- Inhalation Injury
- Rib Fractures due to cardiopulmonary resuscitation
- Life Expectancy \< 6 months
- \> 48 hours from injury
- Pregnant, Incarcerated
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06533904
Start Date
December 1 2025
End Date
September 1 2026
Last Update
October 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Loma Linda University Health
Loma Linda, California, United States, 92354